BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 29348387)

  • 1. Cancer Stem Cells and Molecular Biology Test in Colorectal Cancer: Therapeutic Implications.
    Effendi-Ys R
    Acta Med Indones; 2017 Oct; 49(4):351-359. PubMed ID: 29348387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Updates in colorectal cancer stem cell research.
    Li CJ; Zhang X; Fan GW
    J Cancer Res Ther; 2014 Dec; 10 Suppl():233-9. PubMed ID: 25693926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is There a Role for Programmed Death Ligand-1 Testing and Immunotherapy in Colorectal Cancer With Microsatellite Instability? Part I-Colorectal Cancer: Microsatellite Instability, Testing, and Clinical Implications.
    Marginean EC; Melosky B
    Arch Pathol Lab Med; 2018 Jan; 142(1):17-25. PubMed ID: 29144791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer stem cells in colorectal cancer: a review.
    Munro MJ; Wickremesekera SK; Peng L; Tan ST; Itinteang T
    J Clin Pathol; 2018 Feb; 71(2):110-116. PubMed ID: 28942428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictive Biomarkers in Colorectal Cancer: From the Single Therapeutic Target to a Plethora of Options.
    Rodrigues D; Longatto-Filho A; Martins SF
    Biomed Res Int; 2016; 2016():6896024. PubMed ID: 27563673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New trends in molecular and cellular biomarker discovery for colorectal cancer.
    Aghagolzadeh P; Radpour R
    World J Gastroenterol; 2016 Jul; 22(25):5678-93. PubMed ID: 27433083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostaglandin E2 Promotes Colorectal Cancer Stem Cell Expansion and Metastasis in Mice.
    Wang D; Fu L; Sun H; Guo L; DuBois RN
    Gastroenterology; 2015 Dec; 149(7):1884-1895.e4. PubMed ID: 26261008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical importance of DNA repair in sporadic colorectal cancer.
    Laporte GA; Leguisamo NM; Kalil AN; Saffi J
    Crit Rev Oncol Hematol; 2018 Jun; 126():168-185. PubMed ID: 29759559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New Therapeutic Opportunities Based on DNA Mismatch Repair and BRAF Status in Metastatic Colorectal Cancer.
    Cohen R; Svrcek M; Dreyer C; Cervera P; Duval A; Pocard M; Fléjou JF; de Gramont A; André T
    Curr Oncol Rep; 2016 Mar; 18(3):18. PubMed ID: 26861657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of cancer stem cells from different grades of human colorectal cancer.
    Manhas J; Bhattacharya A; Agrawal SK; Gupta B; Das P; Deo SV; Pal S; Sen S
    Tumour Biol; 2016 Oct; 37(10):14069-14081. PubMed ID: 27507615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Translating colorectal cancer genetics into clinically useful biomarkers.
    Morley-Bunker A; Walker LC; Currie MJ; Pearson J; Eglinton T
    Colorectal Dis; 2016 Aug; 18(8):749-62. PubMed ID: 26990814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High levels of SIRT1 expression enhance tumorigenesis and associate with a poor prognosis of colorectal carcinoma patients.
    Chen X; Sun K; Jiao S; Cai N; Zhao X; Zou H; Xie Y; Wang Z; Zhong M; Wei L
    Sci Rep; 2014 Dec; 4():7481. PubMed ID: 25500546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Possible Role of Cancer Stem Cells in Colorectal Cancer Metastasizing to the Liver.
    Jiao ZY; Cao HT; Li YM
    Curr Stem Cell Res Ther; 2016; 11(5):440-3. PubMed ID: 26832139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Upregulation of circulating cancer stem cell marker, DCLK1 but not Lgr5, in chemoradiotherapy-treated colorectal cancer patients.
    Mirzaei A; Tavoosidana G; Modarressi MH; Rad AA; Fazeli MS; Shirkoohi R; Tavakoli-Yaraki M; Madjd Z
    Tumour Biol; 2015 Jun; 36(6):4801-10. PubMed ID: 25631749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Essential Role of DCLK1 in Pathogenesis, Diagnostic Procedures and Prognostic Stratification of Colorectal Cancer.
    Gzil A; Szylberg Ł; Jaworski D; Dominiak J; Zarębska I; Grzanka D
    Anticancer Res; 2019 Jun; 39(6):2689-2697. PubMed ID: 31177103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting cancer stem cells as therapeutic approach in the treatment of colorectal cancer.
    Parizadeh SM; Jafarzadeh-Esfehani R; Hassanian SM; Parizadeh SMR; Vojdani S; Ghandehari M; Ghazaghi A; Khazaei M; Shahidsales S; Rezayi M; Asgharzadeh F; Ghayour-Mobarhan M; Ferns GA; Avan A
    Int J Biochem Cell Biol; 2019 May; 110():75-83. PubMed ID: 30818083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and molecular features of young-onset colorectal cancer.
    Ballester V; Rashtak S; Boardman L
    World J Gastroenterol; 2016 Feb; 22(5):1736-44. PubMed ID: 26855533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulatory mechanisms of microRNAs in colorectal cancer and colorectal cancer stem cells.
    Shirmohamadi M; Eghbali E; Najjary S; Mokhtarzadeh A; Kojabad AB; Hajiasgharzadeh K; Lotfinezhad P; Baradaran B
    J Cell Physiol; 2020 Feb; 235(2):776-789. PubMed ID: 31264216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD133: An emerging prognostic factor and therapeutic target in colorectal cancer.
    Akbari M; Shomali N; Faraji A; Shanehbandi D; Asadi M; Mokhtarzadeh A; Shabani A; Baradaran B
    Cell Biol Int; 2020 Feb; 44(2):368-380. PubMed ID: 31579983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Research progression in colorectal cancer stem cells].
    Wu TY; Cui L
    Zhonghua Wei Chang Wai Ke Za Zhi; 2013 Mar; 16(3):297-300. PubMed ID: 23536355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.